Published on in Vol 11, No 1 (2022): Jan-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29880, first published .
Quantifying the Impact of COVID-19 on Telemedicine Utilization: Retrospective Observational Study

Quantifying the Impact of COVID-19 on Telemedicine Utilization: Retrospective Observational Study

Quantifying the Impact of COVID-19 on Telemedicine Utilization: Retrospective Observational Study

Emily Louise Vogt   1, 2 , BA ;   Brandon M Welch   3, 4 , PhD ;   Brian E Bunnell   4, 5 , PhD ;   Janelle F Barrera   4, 5 , MPH, CPH, CHES ;   Samantha R Paige   4 , MPH, PhD, CHES ;   Marisa Owens   6 , RHIA ;   Patricia Coffey   6 , MSHIA, RHIA ;   Nancy Diazgranados   2 , MD, MSc ;   David Goldman   2, 7 , MD

1 University of Michigan Medical School, Ann Arbor, MI, United States

2 Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, United States

3 Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC, United States

4 Doxy.me Research, Doxy.me, LLC, Rochester, NY, United States

5 Department of Psychiatry and Behavioral Neurosciences, University of South Florida, Tampa, FL, United States

6 Clinical Center, National Institutes of Health, Bethesda, MD, United States

7 Lab of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD, United States

Corresponding Author:

  • David Goldman, MD
  • Lab of Neurogenetics
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institutes of Health
  • 5625 Fishers Lane
  • Rm 3S-32: MSC 9412
  • Rockville, MD, 20892
  • United States
  • Phone: 1 301-443-0059
  • Email: davidgoldman@mail.nih.gov